SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-171254
Filing Date
2023-06-21
Accepted
2023-06-21 16:59:59
Documents
15
Period of Report
2023-06-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d451541d8k.htm   iXBRL 8-K 24727
2 EX-99.1 d451541dex991.htm EX-99.1 14739
6 GRAPHIC g451541g12u04.jpg GRAPHIC 6678
7 GRAPHIC g451541g85g67.jpg GRAPHIC 20978
  Complete submission text file 0001193125-23-171254.txt   205267

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igms-20230602.xsd EX-101.SCH 2836
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20230602_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20230602_pre.xml EX-101.PRE 11249
9 EXTRACTED XBRL INSTANCE DOCUMENT d451541d8k_htm.xml XML 3351
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 231030625
SIC: 2834 Pharmaceutical Preparations